Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80,853 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II).
Petri M, Bruce IN, Dörner T, Tanaka Y, Morand EF, Kalunian KC, Cardiel MH, Silk ME, Dickson CL, Meszaros G, Zhang L, Jia B, Zhao Y, McVeigh CJ, Mosca M. Petri M, et al. Among authors: zhao y. Lancet. 2023 Mar 25;401(10381):1011-1019. doi: 10.1016/S0140-6736(22)02546-6. Epub 2023 Feb 24. Lancet. 2023. PMID: 36848919 Clinical Trial.
Concomitant Moderate to Severe Cutaneous Lesions Have Marked Impact on Quality of Life in Patients with Active Systemic Lupus Erythematosus: A Cross-Sectional Insight from Two Phase 3 Randomised Clinical Trials in Adults.
Mallbris MJ, Jia B, Zhao Y, Kahlenberg JM, Gudjonsson JE. Mallbris MJ, et al. Among authors: zhao y. Br J Dermatol. 2024 Apr 30:ljae183. doi: 10.1093/bjd/ljae183. Online ahead of print. Br J Dermatol. 2024. PMID: 38687872 No abstract available.
Adherence to guidelines and central line-associated bloodstream infection occurrence during insertion and maintenance of intravascular catheters: evidence from 20 tertiary hospitals.
Zang F, Liu J, Wen Y, Jin X, Yang Y, Li L, Di J, Tang H, Wu J, Liu J, Liu H, Huang J, Zhang J, Li S, Yang L, Wang X, Geng S, Xing H, Xie J, Hua J, Xue X, Zhao Y, Ouyang L, Song P, Zhuang G, Chen W. Zang F, et al. Among authors: zhao y. J Hosp Infect. 2024 Jun 3:S0195-6701(24)00196-8. doi: 10.1016/j.jhin.2024.05.011. Online ahead of print. J Hosp Infect. 2024. PMID: 38838743
Safety of pembrolizumab as adjuvant therapy in a pooled analysis of phase 3 clinical trials of melanoma, non-small cell lung cancer, and renal cell carcinoma.
Luke JJ, Long GV, Robert C, Carlino MS, Choueiri TK, Haas NB, O'Brien M, Paz-Ares L, Peters S, Powles T, Leiby MA, Lin J, Zhao Y, Krepler C, Perini RF, Catherine Pietanza M, Samkari A, Gruber T, Ibrahim N, Eggermont AMM. Luke JJ, et al. Among authors: zhao y. Eur J Cancer. 2024 May 31;207:114146. doi: 10.1016/j.ejca.2024.114146. Online ahead of print. Eur J Cancer. 2024. PMID: 38838446
80,853 results
You have reached the last available page of results. Please see the User Guide for more information.